When recombinant DNA technology made possible the synthesis of mammalian proteins in unlimited quantities, human growth hormone was an obvious candidate. The refined synthetic product is now being tested in children with somatotropin deficiency, with early indications of efficacy and safety. Future research may point to other therapeutic uses of synthetic hGH.
|Original language||English (US)|
|Number of pages||10|
|State||Published - Dec 1 1983|
ASJC Scopus subject areas